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1 
Sub-display channel: Science Forum 1 
Title: The Human Cell Atlas 2 
Abstract: The recent advent of methods for high-throughput single-cell molecular 3 
profiling has catalyzed a growing sense in the scientific community that the time is 4 
ripe to complete the 150-year-old effort to identify all cell types in the human body. 5 
The Human Cell Atlas Project is an international collaborative effort that aims to 6 
define all human cell types in terms of distinctive molecular profiles (such as gene 7 
expression profiles) and to connect this information with classical cellular 8 
descriptions (such as location and morphology). An open comprehensive reference 9 
map of the molecular state of cells in healthy human tissues would propel the 10 
systematic study of physiological states, developmental trajectories, regulatory 11 
circuitry and interactions of cells, and also provide a framework for understanding 12 
cellular dysregulation in human disease. Here we describe the idea, its potential 13 
utility, early proofs-of-concept, and some design considerations for the Human Cell 14 
Atlas, including a commitment to open data, code, and community. 15 
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<L1>Introduction</L1> 151 
The cell is the fundamental unit of living organisms. Hooke reported the discovery of cells 152 
in plants in 1665 (Hooke, 1665) and named them for their resemblance to the cells 153 
inhabited by monks, but it took nearly two centuries for biologists to appreciate their 154 
central role in biology. Between 1838 and 1855, Schleiden, Schwann, Remak, Virchow and 155 
others crystalized an elegant Cell Theory (Harris, 2000), stating that all organisms are 156 
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composed of one or more cells; that cells are the basic unit of structure and function in 157 
life; and that all cells are derived from pre-existing cells (Mazzarello, 1999; Figure 1).  158 
To study human biology, we must know our cells. Human physiology emerges 159 
from normal cellular functions and intercellular interactions. Human disease entails the 160 
disruption of these processes and may involve aberrant cell types and states, as seen in 161 
cancer. Genotypes give rise to organismal phenotypes through the intermediate of cells, 162 
because cells are the basic functional units, each regulating their own program of gene 163 
expression. Therefore, genetic variants that contribute to disease typically manifest their 164 
action through impact in a particular cell types: for example, genetic variants in the IL23R 165 
locus increase risk of autoimmune diseases by altering the function of dendritic cells and 166 
T-cells (Duerr et al., 2006), and DMD mutations cause muscular dystrophy through 167 
specific effects in skeletal muscle cells (Murray et al., 1982).  168 
For more than 150 years, biologists have sought to characterize and classify cells 169 
into distinct types based on increasingly detailed descriptions of their properties, 170 
including their shape, their location and relationship to other cells within tissues, their 171 
biological function, and, more recently, their molecular components. At every step, efforts 172 
to catalog cells have been driven by advances in technology. Improvements in light 173 
microscopy were obviously critical. So too was the invention of synthetic dyes by chemists 174 
(Nagel, 1981), which biologists rapidly found stained cellular components in different ways 175 
(Stahnisch, 2015). In pioneering work beginning in 1887, Santiago Ramón y Cajal applied a 176 
remarkable staining process discovered by Camillo Golgi to show that the brain is 177 
composed of distinct neuronal cells, rather than a continuous syncytium, with stunningly 178 
diverse architectures found in specific anatomical regions (Ramón y Cajal, 1995); the pair 179 
shared the 1906 Nobel Prize in Physiology or Medicine for their work.  180 
Starting in the 1930s, electron microscopy provided up to 5000-fold higher 181 
resolution, making it possible to discover and distinguish cells based on finer structural 182 
features. Immunohistochemistry, pioneered in the 1940s (Arthur, 2016) and accelerated by 183 
the advent of monoclonal antibodies (Kohler and Milstein, 1975) and Fluorescence-184 
Activated Cell Sorting (FACS; Dittrich and Göhde, 1971; Fulwyler, 1965) in the 1970s, made 185 
it possible to detect the presence and levels of specific proteins. This revealed that 186 
morphologically indistinguishable cells can vary dramatically at the molecular level and 187 
led to exceptionally fine classification systems, for example, of hematopoietic cells, based 188 
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on cell-surface markers. In the 1980s, Fluorescence in situ Hybridization (FISH; Langer-189 
Safer et al., 1982) enhanced the ability to characterize cells by detecting specific DNA loci 190 
and RNA transcripts. Along the way, studies showed that distinct molecular phenotypes 191 
typically signify distinct functionalities. Through these remarkable efforts, biologists have 192 
achieved an impressive understanding of specific systems, such as the hematopoietic and 193 
immune systems (Chao et al., 2008; Jojic et al., 2013; Kim and Lanier, 2013) or the neurons 194 
in the retina (Sanes and Masland, 2015).  195 
Despite this progress, our knowledge of cell types remains incomplete.  Moreover, 196 
current classifications are based on different criteria, such as morphology, molecules and 197 
function, which have not always been related to each other. In addition, molecular 198 
classification of cells has largely been ad hoc – based on markers discovered by accident or 199 
chosen for convenience – rather than systematic and comprehensive. Even less is known 200 
about cell states and their relationships during development: the full lineage tree of cells 201 
from the single-cell zygote to the adult is only known for the nematode C. elegans, which 202 
is transparent and has just ~1000 cells.  203 
At a conceptual level, one challenge is that we lack a rigorous definition of what 204 
we mean by the intuitive terms 'cell type' and 'cell state'. Cell type often implies a notion 205 
of persistence (e.g., being a hepatic stellate cell or a cerebellar Purkinje cell), while cell 206 
state often refers to more transient properties (e.g., being in the G1 phase of the cell cycle 207 
or experiencing nutrient deprivation). But, the boundaries between these concepts can be 208 
blurred, because cells change over time in ways that are far from fully understood. 209 
Ultimately, data-driven approaches will likely refine our concepts.  210 
The desirability of having much deeper knowledge about cells has been well 211 
recognized for a long time (Brenner, 2010; Eberwine et al., 1992; Shapiro, 2010; Van Gelder 212 
et al., 1990). However, only in the past few years has it begun to seem feasible to 213 
undertake the kind of systematic, high-resolution characterization of human cells 214 
necessary to create a systematic cell atlas. 215 
The key has been the recent ability to apply genomic profiling approaches to single 216 
cells. By 'genomic approaches' we mean methods for large-scale profiling of the genome 217 
and its products, including DNA sequence, chromatin architecture, RNA transcripts, 218 
proteins, and metabolites (Lander, 1996). It has long been appreciated that such methods 219 
provide rich and comprehensive descriptions of biological processes. Historically, 220 
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however, they could only be applied to bulk tissue samples comprised of an ensemble of 221 
many cells, providing average genomic measures for a sample, but masking their 222 
differences across cells. The result is as unsatisfying as trying to understand New York, 223 
London or Mumbai based on the average properties of their inhabitants.  224 
The first single-cell genomic characterization method to become feasible at large-225 
scale is trancriptome analysis by single cell RNA-Seq (Box 1; Hashimshony et al., 2012; 226 
Jaitin et al., 2014; Picelli et al., 2013; Ramskold et al., 2012; Shalek et al., 2013). Initial efforts 227 
first used microarrays and then RNA-seq to profile RNA from small numbers of single 228 
cells, which were obtained either by manual picking from in situ fixed tissue, using flow-229 
sorting or, later on, with microfluidic devices, adapted from devices developed initially for 230 
qPCR-based approaches (Crino et al., 1996; Dalerba et al., 2011; Marcus et al., 2006; 231 
Miyashiro et al., 1994; Zhong et al., 2008). Now, massively parallel assays can process tens 232 
and hundreds of thousands of single cells simultaneously to measure their transcriptional 233 
profiles at rapidly decreasing costs (Klein et al., 2015; Macosko et al., 2015; Shekhar et al., 234 
2016) with increasing accuracy and sensitivity (Svensson et al., 2016; Ziegenhain et al., 235 
2016). In some cases, it is even possible to register these sorted cells to their spatial 236 
positions in images (Vickovic et al., 2016). Single-cell RNA sequencing (scRNA-seq) is 237 
rapidly becoming widely disseminated.  238 
Following this initial wave of technologies are many additional methods at various 239 
stages of development and high-throughput implementation. Techniques are being 240 
developed to assay: in situ gene expression in tissues at single-cell and even sub-cellular 241 
resolution (Chen et al., 2015b; Ke et al., 2013; Lee et al., 2014; Lubeck et al., 2014; Shah et al., 242 
2016; Stahl et al., 2016); the distribution of scores of proteins at cellular or sub-cellular 243 
resolution (Angelo et al., 2014; Chen et al., 2015a; Giesen et al., 2014; Hama et al., 2011; 244 
Susaki et al., 2014; Yang et al., 2014); various aspects of chromatin state (Buenrostro et al., 245 
2015; Cusanovich et al., 2015; Farlik et al., 2015; Guo et al., 2013; Lorthongpanich et al., 2013; 246 
Mooijman et al., 2016; Rotem et al., 2015a; Rotem et al., 2015b; Smallwood et al., 2014); and 247 
DNA mutations to allow precise reconstruction of cell lineages (Behjati et al., 2014; 248 
Biezuner et al., 2016; Shapiro et al., 2013; Taylor et al., 2003; Teixeira et al., 2013). Various 249 
groups are also developing single-cell multi-omic methods to simultaneously measure 250 
several types of molecular profiles in the same cell (Albayrak et al., 2016; Angermueller et 251 
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al., 2016; Behjati et al., 2014; Darmanis et al., 2016; Dey et al., 2015; Frei et al., 2016; 252 
Genshaft et al., 2016; Macaulay et al., 2015).  253 
 As a result, there is a growing sense in the scientific community that the time is 254 
now right for a project to complete the Human Cell Atlas that pioneering histologists 255 
began 150 years ago. Various discussions have taken place in a number of settings over the 256 
past two years, culminating in an international meeting in London in October 2016. In 257 
addition, several pilot efforts are already underway or in planning – for example, related to 258 
brain cells and immune cells. Prompted by such efforts, funding agencies, including the 259 
NIH, have sought information from the scientific community about the notion of creating 260 
cell or tissue atlases. 261 
The goal of this article is to engage the wider scientific community in this 262 
conversation. Although the timing is driven by technologies that have recently appeared 263 
or are expected to mature in the near-future, the project itself is fundamentally an 264 
intellectual endeavor. We therefore articulate the concept of a cell atlas and explore its 265 
potential utility for biology and medicine. We discuss how an atlas can lead to new 266 
understanding of histology, development, physiology, pathology, and intra- and inter-267 
cellular regulation, and enhance our ability to predict the impact of perturbations on cells. 268 
It will also yield molecular tools with applications in both research and clinical practice. 269 
As discussed below, a Human Cell Atlas Project would be a shared international 270 
effort involving diverse scientific communities. More details are available in the Human 271 
Cell Atlas White Paper 272 
(https://www.humancellatlas.org/files/HCA_WhitePaper_18Oct2017.pdf): the first version 273 
of this 'living document', which will updated on a regular basis, was released on October 274 
18, 2017. 275 
 276 
<L1>What is the Human Cell Atlas, and what could we learn from it?</L1> 277 
At its most basic level, the Human Cell Atlas must include a comprehensive 278 
reference catalog of all human cells based on their stable properties and transient features, 279 
as well as their locations and abundances. Yet, an atlas is more than just a catalog: it is a 280 
map that aims to show the relationships among its elements. By doing so, it can 281 
sometimes reveal fundamental processes – akin to how the atlas of Earth suggested 282 
continental drift through the correspondence of coastlines.  283 
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To be useful, an atlas must also be an abstraction, comprehensively representing 284 
certain features, while ignoring others. The writer Jorge Luis Borges – a master at 285 
capturing the tension between grandeur and grandiosity – distilled this challenge in his 286 
one-paragraph story, "On Exactitude in Science", about an empire enamored with science 287 
of cartography (Box 2; Borges and Hurley, 2004). Over time, the cartographers' map of the 288 
realm grew more and more elaborate, and hence bigger, until – expandio ad absurdum – 289 
the map reached the size of the entire empire itself and became useless. 290 
Moreover, an atlas must provide a system of coordinates on which one can 291 
represent and harmonize concepts at many levels (geopolitical borders, topography, roads, 292 
climate, restaurants, and even dynamic traffic patterns). Features can be viewed at any 293 
level of magnification, and high-dimensional information collapsed into simpler views. 294 
So, a key question is how a Human Cell Atlas should abstract key features, provide 295 
coordinates, and show relationships. A natural solution would be to describe each human 296 
cell by a defined set of molecular markers. For example, one might describe each cell by 297 
the expression level of each of the ~20,000 human protein-coding genes: that is, each cell 298 
would be represented as a point in ~20,000-dimensional space. Of course, the set of 299 
markers could be expanded to include the expression levels of non-coding genes, the 300 
levels of the alternatively spliced forms of each transcript, the chromatin state of every 301 
promoter and enhancer, and the levels of each protein or each post-translationally 302 
modified form of each protein. The optimal amount and type of information to collect will 303 
emerge based on a balance of technological feasibility and the biological insight provided 304 
by each layer (Corces et al., 2016; Lorthongpanich et al., 2013; Paul et al., 2015). For specific 305 
applications, it will be useful to employ reduced representations. Solely for concreteness, 306 
we will largely refer below to the 20,000-dimensional space of gene expression, which can 307 
already be assayed at high-throughput. 308 
The Atlas should have additional coordinates or annotations to represent 309 
histological and anatomical information (e.g., a cell's location, morphology, or tissue 310 
context), temporal information (e.g., the age of the individual or time since an exposure), 311 
and disease status. Such information is essential for harmonizing results based on 312 
molecular profiles with rich knowledge about cell biology, histology and function. How 313 
best to capture and represent this information requires serious attention. 314 
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In some respects, the Human Cell Atlas Project (whose fundamental unit is a cell) 315 
is analogous to the Human Genome Project (whose fundamental unit is a gene). Both are 316 
ambitious efforts to create 'Periodic Tables' for biology that comprehensively enumerate 317 
the two key 'atomic' units that underlie human life (cells and genes) and thereby provide a 318 
crucial foundation for biological research and medical application. As with the Human 319 
Genome Project, we will also need corresponding atlases for important model organisms, 320 
where conserved cell states can be identified and genetic manipulations and other 321 
approaches can be used to probe function and lineage. Yet, the Human Cell Atlas differs in 322 
important ways from the Human Genome Project: the nature of cell biology means that it 323 
will require a distinct experimental toolbox, and will involve making choices concerning 324 
molecular and cellular descriptors. Assessing the distance to completion will also be a 325 
challenge.  326 
As a Borgesian thought experiment, we could conceive of an imaginary Ultimate 327 
Human Cell Atlas that represents: all markers in every cell in a person's body; every cell's 328 
spatial position (by adding three dimensions for the body axes); every cell at every 329 
moment of a person's lifetime (by adding another dimension for time relating the cells by 330 
a lineage); and the superimposition of such cell atlases from every human being, 331 
annotated according to differences in health, genotype, lifestyle and environmental 332 
exposure.  333 
Of course, it is not possible to construct such an Ultimate Atlas. However, it is 334 
increasingly feasible to sample richly from the distribution of points to understand the key 335 
features and relationships among all human cells. We return below to the question of how 336 
the scientific community might go about creating a Human Cell Atlas. First, we consider 337 
the central scientific question: What could we hope to learn from such an atlas?  338 
 A Human Cell Atlas would have a profound impact on biology and medicine by 339 
bringing our understanding of anatomy, development, physiology, pathology, intracellular 340 
regulation, and intercellular communication to a new level of resolution. It would also 341 
provide invaluable markers, signatures and tools for basic research (facilitating detection, 342 
purification and genetic manipulation of every cell type) and clinical applications 343 
(including diagnosis, prognosis and monitoring response to therapy). 344 
In the following sections, we outline reasonable expectations and describe some 345 
early examples. We recognize that these concepts will evolve based on emerging data. It is 346 
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clear that a Human Cell Atlas Project will require and will motivate the development of 347 
new technologies. It will also necessitate the creation of new mathematical frameworks 348 
and computational approaches that may have applications far beyond biology – perhaps 349 
analogous to how biological 'big data' in agriculture in the 1920s led to the creation, by 350 
R.A. Fisher and others, of key statistical methods, including the analysis of variance and 351 
experimental design (Parolini, 2015). 352 
 353 
<L1>Taxonomy: cell types</L1> 354 
The most fundamental level of analysis is the identification of cell types. In an atlas 355 
where cells are represented as points in a high-dimensional space, 'similar' cells should be 356 
'close' in some appropriate sense, although not identical, owing to differences in 357 
physiological states (e.g., cell-cycle stage), the inherent noise in molecular systems (Eldar 358 
and Elowitz, 2010; Kharchenko et al., 2014; Kim et al., 2015; Shalek et al., 2013), and 359 
measurement errors (Buettner et al., 2015; Kharchenko et al., 2014; Kim et al., 2015; Shalek 360 
et al., 2013; Shalek et al., 2014; Wagner et al., 2016). Thus, a cell 'type' might be defined as a 361 
region or a probability distribution (Kim and Eberwine, 2010; Sul et al., 2012) either in the 362 
full-dimensional space or in a projection onto a lower-dimensional space that reflects 363 
salient features.  364 
 While this notion is intuitively compelling, it is challenging to give a precise 365 
definition of a 'cell type'. Cell-type taxonomies are often represented as hierarchies based 366 
on morphological, physiological, and molecular differences (Sanes and Masland, 2015). 367 
Whereas higher distinctions are easily agreed upon, finer ones may be less obvious and 368 
may not obey a strict hierarchy, either because distinct types share features, or because 369 
some distinctions are graded and not discrete. Critically, it remains unclear whether 370 
distinctions based on morphological, molecular and physiological properties agree with 371 
each other. New computational methods will be required both to discover types and to 372 
better classify cells and, ultimately, to refine the concepts themselves (Grun and van 373 
Oudenaarden, 2015; Shapiro et al., 2013; Stegle et al., 2015; Tanay and Regev, 2017; Wagner 374 
et al., 2016). Unsupervised clustering algorithms for high-dimensional data provide an 375 
initial framework (Grun et al., 2015; Grun et al., 2016; Jaitin et al., 2014; Levine et al., 2015; 376 
Macosko et al., 2015; Shekhar et al., 2016; Vallejos et al., 2015), but substantial advances will 377 
be needed in order to select the 'right' features, the 'right' similarity metric, and the 'right' 378 
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level of granularity for the question at hand, control for distinct biological processes, 379 
handle technical noise, and connect novel clusters with legacy knowledge. Whereas cell 380 
types are initially defined based on regions in feature space, it will be important eventually 381 
to distill them into simpler molecular and morphological signatures that can be used to 382 
index cells in the atlas, aggregate and compare results from independent labs and different 383 
individuals, and create tools and reagents for validation and follow up studies.  384 
For all the reasons above, we have not attempted to propose a precise definition of 385 
'cell type'. Rather, the definition should evolve based on empirical observation.  386 
Despite these challenges, recent studies in diverse organs – including immune, 387 
nervous, and epithelial tissues – support the prospects for comprehensive discovery of cell 388 
types, as well as harmonization of genomic, morphological, and functional classifications 389 
(Figure 2A-C). For example, analysis of immune cells from mouse spleen (Jaitin et al., 390 
2014) and human blood (Horowitz et al., 2013) showed that well-established functional 391 
immune cell types and subtypes could be readily distinguished by unsupervised clustering 392 
of single-cell expression profiles. Similarly, single-cell expression profiles of epithelial cells 393 
from gut organoids (Grun et al., 2015) distinguished known cell subtypes, each with 394 
distinctive functional and histological characteristics, while also revealing a new subtype 395 
of enteroendocrine cells, which was subsequently validated experimentally.  396 
The nervous system, where many cell types have not yet been characterized by any 397 
means, illustrates both the promise and the challenge.  Whereas each of the 302 individual 398 
neurons in C. elegans can be distinctly defined by its lineage, position, connectivity, 399 
molecular profile and functions, the extent to which the ~ 1011 neurons in the human brain 400 
are distinctly defined by morphological, physiological, lineage, connectivity, and 401 
electrical-activity criteria, and have distinct molecular profiles, remains unknown.  402 
Cellular neuroanatomy is deeply rooted in the concept of cell types defined by their 403 
morphologies (a proxy for connectivity) and electrophysiological properties (Ascoli et al., 404 
2008), and extensive efforts continue to classify the types in complicated structures like 405 
the retina and neocortex (Jiang et al., 2015; Markram et al., 2015; Sanes and Masland, 2015). 406 
Critically, it remains unclear whether distinctions based on morphological, connectional, 407 
and physiological properties agree with their molecular properties.   408 
The mouse retina provides an ideal testing ground to test this correspondence 409 
because cell types follow highly stereotyped spatial patterns (Macosko et al., 2015; Sanes 410 
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and Masland, 2015). Analysis of 31,000 retinal bipolar cells (Shekhar et al., 2016) 411 
automatically re-discovered the 13 subtypes that had been defined over the past quarter-412 
century based on morphology and lamination, while also revealing two new subtypes with 413 
distinct morphological and laminar characteristics. These subtypes included one with a 414 
'bipolar' expression pattern and developmental history, but a unipolar morphology in the 415 
adult (Shekhar et al., 2016), which has distinct functional characteristics in the neural 416 
circuits of the retina (Della Santina et al., 2016). In this example, known morphological 417 
and other non-molecular classifications matched perfectly to molecular types, and new 418 
molecularly-defined cell types discovered in the single-cell transcriptomic analysis 419 
corresponded to unique new morphology and histology. In other complex brain regions 420 
such as the neocortex and hippocampus there are also a large number of transcriptionally 421 
defined types (Darmanis et al., 2015; Gokce et al., 2016; Habib et al., 2016a; Lake et al., 2016; 422 
Pollen et al., 2014; Tasic et al., 2016; Zeisel et al., 2015), but it has been more difficult to find 423 
consensus between data modalities, and the relationship between transcriptomic types 424 
and anatomical or morphological types is unclear.  In this light, technologies that can 425 
directly measure multiple cellular phenotypes are essential.  For example, 426 
electrophysiological measurements with patch clamping followed by scRNA-seq used in a 427 
recent study of a particular inhibitory cortical cell type showed that the transcriptome 428 
correlated strongly with the cell's physiological state (Cadwell et al., 2016; Foldy et al., 429 
2016).  Thus, the transcriptome appears to provide a proxy for other neuronal properties, 430 
but much more investigation is needed. 431 
 432 
<L1>Histology: Cell neighborhood and position</L1> 433 
Histology examines the spatial position of cells and molecules within tissues. Over 434 
the past century, we have learnt a great deal about cell types, markers, and tissue 435 
architecture, and this body of knowledge will need to be further refined and woven 436 
seamlessly into the Human Cell Atlas. With emerging highly multiplexed methods for in 437 
situ hybridization (Chen et al., 2015b; Shah et al., 2016) or protein staining (Angelo et al., 438 
2014; Giesen et al., 2014), it should be possible to spatially map multiple cell types at once 439 
based on expression signatures to see how they relate to each other and to connect them 440 
with cell types defined by morphology or function. It should also be possible to extend 441 
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observations of continuous gradients for individual genes (such as morphogens) to multi-442 
gene signatures.  443 
Computational approaches could then allow iterative refinement of cellular 444 
characterization based on both a cell's molecular profile and information about its 445 
neighborhood; methods perfected in the analysis of networks could provide a helpful 446 
starting point (Blondel et al., 2008; Rosvall and Bergstrom, 2008). Conversely, expression 447 
data from a cell can help map its position in absolute coordinates or relative terms, as well 448 
as in the context of pathology, highlighting how disease tissue differs from typical healthy 449 
tissue. Combining molecular profiles with tissue architecture will require new 450 
computational methods, drawing perhaps on advances in machine vision (Xu et al., 2015; 451 
Zheng et al., 2015). 452 
New methods for integrating single-cell genomics data into a spatial context have 453 
been developed recently. Single-cell analyses of tissues from early embryos (Satija et al., 454 
2015; Scialdone et al., 2016) to adult (Achim et al., 2015) demonstrate how physical 455 
locations can be imprinted in transcriptional profiles (Durruthy-Durruthy et al., 2014) and 456 
can be used to infer tissue organization (Figure 2D). In the early zebrafish embryo, for 457 
example, a cell's expression profile specifies its location to within a small neighborhood of 458 
~100 cells; the related expression patterns of individual genes in turn fall into only nine 459 
spatial archetypes (Satija et al., 2015). In the early mouse embryo, key spatial gradients can 460 
be recovered by a 'pseudospace' inferred from reduced dimensions of single cell profiles 461 
(Scialdone et al., 2016). In adult mouse hippocampus, cell profiles show clear clusters 462 
corresponding to discrete functional regions as well as gradients following dorsal/ventral 463 
and medial/lateral axes (Habib et al., 2016a). In the annelid brain, even finer punctate 464 
spatial patterns can be resolved (Achim et al., 2015).  465 
 466 
<L1>Development: transitions to differentiated cell types</L1> 467 
Cells arrive at their final differentiated cell types through partly asynchronous 468 
branching pathways of development (Ferrell, 2012), which are driven by and reflected in 469 
molecular changes, especially gene-expression patterns (see, for example, Chao et al., 470 
2008; Jojic et al., 2013). It should therefore be possible to reconstruct development as 471 
trajectories in high-dimensional space, mirroring Waddington's landscape (Ferrell, 2012; 472 
Waddington, 1957) – just as it would be possible to infer the ski lifts and trails on a 473 
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mountain from snapshots of the positions of enough skiers. One can even infer sharp 474 
transitions, provided enough cells are observed. The required sampling density will 475 
depend on the number and complexity of paths and intersections, and sorting strategies 476 
can help to iteratively enrich for rare, transient populations. Notably, the relative 477 
proportions of cells observed at different points along the developmental paths can help 478 
convey critical information, both about the duration of each phase (Antebi et al., 2013; 479 
Kafri et al., 2013) and the balance of how progenitor cells are allocated among fates 480 
(Antebi et al., 2013; Lönnberg et al., 2017; Moris et al., 2016), especially when information 481 
about the rate of cell proliferation and/or death can be incorporated as inferred from the 482 
profiles.  483 
In animal models, it should be possible to create true lineage trees by marking a 484 
common progenitor cell type. For example, one might use synthetic circuits that introduce 485 
a molecular barcode only in cells expressing an RNA pattern characteristic of the cell type 486 
in order to recognize its descendants (Gagliani et al., 2015; McKenna et al., 2016). In 487 
humans, immune cells naturally contain lineage barcodes through VDJ recombination in 488 
T and B cells and somatic hypermutation in B cells (Stubbington et al., 2016). More 489 
generally, it may be feasible to accomplish lineage tracing in human cells by taking 490 
advantage of the steady accumulation of DNA changes (such as somatic point mutations, 491 
or repeat expansions at microsatellite loci) at each cell division (Behjati et al., 2014; 492 
Biezuner et al., 2016; Martincorena et al., 2015; Reizel et al., 2012; Shlush et al., 2012) or as a 493 
molecular clock (Taylor et al., 2003; Teixeira et al., 2013). 494 
Initial computational methods have already been developed for inferring dynamic 495 
trajectories from large numbers of single-cell profiles, although better algorithms are still 496 
needed. Critical challenges include accurately inferring branching structures, where two 497 
or more paths diverge from a single point; reconstructing 'fast' transitions, where only few 498 
cells can be captured; and accounting for the fact that a cell may be following multiple 499 
dynamic paths simultaneously – for example, differentiation, the cell cycle, and pathogen 500 
response (see below) – that may affect each other. The reconstruction algorithms 501 
themselves could incorporate insights from theoretical studies of dynamical systems, and 502 
learned models could be analyzed in light of such frameworks (Ferrell, 2012; May, 1976; 503 
Thom, 1989). 504 
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Recent studies provide proofs-of-principle for how simultaneous and orthogonal 505 
biological processes can be inferred from single-cell RNA-seq data (Figure 3; Angerer et 506 
al., 2016; Bendall et al., 2014; Chen et al., 2016b; Haghverdi et al., 2015; Haghverdi et al., 507 
2016; Lönnberg et al., 2017; Marco et al., 2014; Moignard et al., 2015; Setty et al., 2016; 508 
Trapnell et al., 2014; Treutlein et al., 2016). Linear developmental trajectories have been 509 
reconstructed, for example, from single-cell protein expression during B-cell 510 
differentiation (Bendall et al., 2014), and from single-cell RNA expression during 511 
myogenesis in vitro (Trapnell et al., 2014), early hematopoiesis (Nestorowa et al., 2016), 512 
neurogenesis in vivo (Habib et al., 2016a; Shin et al., 2015), and reprogramming from 513 
fibroblasts to neurons (Treutlein et al., 2016). With a large enough number of cells, 514 
analysis of B-cell development was able to highlight a rare (0.007%) population 515 
corresponding to the earliest B-cell lymphocytes and confirm the identification by 516 
reference to rearrangements at the IgH locus. In direct reprogramming to neurons, 517 
scRNA-seq revealed unexpected trajectories (Treutlein et al., 2016). Bifurcated trajectories 518 
have also been reconstructed in the differentiation of embryonic stem cells, T helper cells, 519 
and hematopoietic cells (Chen et al., 2016b; Haghverdi et al., 2015; Haghverdi et al., 2016; 520 
Lönnberg et al., 2017; Marco et al., 2014; Moignard et al., 2015; Setty et al., 2016), and have 521 
helped address open questions about whether myeloid progenitor cells in bone marrow 522 
are already skewed towards distinct fates (Olsson et al., 2016; Paul et al., 2015) and when T 523 
helper cell commit to their fate (Lönnberg et al., 2017). 524 
 525 
<L1>Physiology and homeostasis: cycles, transient responses and plastic states</L1> 526 
In addition to development and differentiation, cells are constantly undergoing 527 
multiple dynamic processes of physiological change and homeostatic regulation (Yosef 528 
and Regev, 2011, 2016). These include cyclical processes, such as the cell cycle and circadian 529 
rhythms; transient responses to diverse factors, from nutrients and microbes to 530 
mechanical forces and tissue damage; and plastic states that can be stably maintained over 531 
longer time scales, but can change in response to new environmental cues. (The precise 532 
boundary between plastic states and cell types, it must be noted, remains to be clarified.) 533 
The molecular phenotype of a cell reflects a superposition of these various processes and 534 
their interactions (Wagner et al., 2016). 535 
 
 
 
 
18 
Studies of physiological processes from bulk tissue samples are hampered by 536 
asynchrony and heterogeneity among cells, which blur the signals of individual processes 537 
and states; investigators strive to create homogeneous cell populations through 538 
synchronization and purification. By contrast, single-cell analysis exploits asynchrony and 539 
heterogeneity, leveraging variation within a cell population to reveal underlying 540 
structures. The difference is analogous to two approaches in structural biology: X-ray 541 
crystallography, which requires molecules to be in a crystalline order, and cryo-electron 542 
microscopy, which depends on observing large numbers of molecules in randomly 543 
sampled poses. 544 
From asynchronous observations of cyclical and transient processes, it should be 545 
possible to 'order' cells with respect to the process (as for development), with cell 546 
proportions reflecting residence time (e.g., the length of a phase of the cell cycle). As was 547 
initially shown for single-cell measurement of a few features of the cell cycle (Kafri et al., 548 
2013), analysis of many systems could yield a near-continuous model of the process, 549 
provided that a sufficient number of cells is sampled. This can occur either because all 550 
phases co-occur (e.g., in asynchronously cycling cells) or because enough time points are 551 
sampled to span the full process. If very rapid and dramatic discontinuities exist, 552 
recovering them would likely require direct tracing, for example by genetic tracers or live 553 
analysis in cell cultures, organoids, or animal models.  554 
Once the cells are ordered, one can derive gene-signatures that reflect each phase 555 
and use them to further sharpen and refine the model. With sufficient data, it should also 556 
be possible to tease apart interactions among processes occurring in parallel (such as the 557 
cell cycle, response to a pathogen, and differentiation). For plastic states, it may be 558 
possible to capture transient transitions between them, especially if they can be enriched 559 
by appropriate physiological cues. Finally, we will likely learn about the nature of stable 560 
states: while we often think of stable states as discrete attractor basins (Waddington, 561 
1957), there may also be troughs that reflect a continuous spectrum of stable states (e.g., 562 
the ratio of two processes may vary across cells, but are stable in each; Antebi et al., 2013; 563 
Gaublomme et al., 2015; Huang, 2012, 2013; Rebhahn et al., 2014; Zhou et al., 2012; Zhou et 564 
al., 2016). Some key aspects of processes may be difficult to uncover solely from 565 
observations of transitions among molecular states, and will likely require directed 566 
perturbations and detailed mechanistic studies.  567 
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Recent studies have shown that cyclical processes and transient responses – from 568 
the cell cycle (Buettner et al., 2015; Gut et al., 2015; Kafri et al., 2013; Kowalczyk et al., 2015; 569 
Macosko et al., 2015; Proserpio et al., 2016; Tirosh et al., 2016a) to the response of immune 570 
cells to pathogen components (Avraham et al., 2015; Shalek et al., 2013; Shalek et al., 2014) 571 
– can be traced in single-cell profiles. It is possible to order the cells temporally, define 572 
coordinately expressed genes with high precision, identify the time scale of distinct 573 
phases, and relate these findings to orthogonal measures (Figure 4). For example, in the 574 
cell cycle, analysis of single-cell profiles readily shows a robust, reproducible and 575 
evolutionarily conserved program that can be resolved in a near-continuous way across 576 
human and mouse cell lines (Macosko et al., 2015), primary immune cells (Buettner et al., 577 
2015; Kowalczyk et al., 2015), and healthy and disease tissues (Patel et al., 2014; Tirosh et 578 
al., 2016a; Tirosh et al., 2016b). This approach has made it possible to determine the 579 
relative rates of proliferation of different cell subpopulations within a dataset (Buettner et 580 
al., 2015; Kolodziejczyk et al., 2015; Kowalczyk et al., 2015; Tsang et al., 2015), a feat difficult 581 
to accomplish using bulk synchronized populations along the cell cycle (Bar-Joseph et al., 582 
2008; Lu et al., 2007). Notably, the cell cycle could also be reconstructed by similar 583 
approaches when applied to imaging data of very few molecular markers along with 584 
salient spatial features (Gut et al., 2015) or with morphology alone (Blasi et al., 2016; 585 
Eulenberg et al., 2017). Similar principles apply to transient responses. In the response of 586 
dendritic cells to pathogen components, single-cell profiling uncovered a small subset 587 
(<1%) of 'precocious' cells: these early-appearing cells express a distinctive module of 588 
genes, initiate production of interferon beta, and coordinate the subsequent response of 589 
other cells through paracrine signaling (Shalek et al., 2014).  590 
 591 
<L1>Disease: Cells and cellular ecosystems</L1> 592 
The Human Cell Atlas will be a critical reference for studying disease, which 593 
invariably involves disruption of normal cellular functions, interactions, proportions, or 594 
ecosystems. The power of single-cell analysis of disease is evident from decades of 595 
histopathological studies and FACS analysis. It will be substantially extended by the 596 
routine ability to characterize cells and tissues with rich molecular signatures, rather than 597 
focusing on a limited number of pre-defined markers or cell populations. It will also 598 
support the growing interest in understanding interactions between frankly abnormal 599 
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cells and all other cells in a tissue's ecosystem in promoting or suppressing disease 600 
processes (e.g., between malignant cells and the tumor microenvironment).  601 
Single-cell analysis of disease samples will also likely be critical to see the full 602 
range of normal cellular physiology, because disease either elicits key perturbs cellular 603 
circuitry in informative ways. A clear example is the immune system, where only in the 604 
presence of a 'challenge' is the full range of appropriate physiological behaviors and 605 
potential responses by a cell revealed.  606 
Single-cell information across many patients will allow us to learn about how cell 607 
proportions and states vary and how this variation correlates with genome variants, 608 
disease course and treatment response. From initial studies of a limited number of 609 
patients, it should be possible to derive signatures of key cell types and states and use 610 
them to deconvolute cellular proportions in conventional bulk-tissue or blood samples 611 
(Levine et al., 2015; Tirosh et al., 2016a). Future studies may expand single-cell analysis to 612 
thousands of patients to directly investigate how genetic variation affects gene 613 
transcription and regulation. 614 
The hematopoietic system will be an early and fruitful target. A study involving 615 
signatures of cell-signaling assays by single-cell mass cytometry of healthy hematopoietic 616 
cells led to more accurate classification of hematopoietic stem and progenitor cells 617 
(HSPCs) in Acute Myeloid Leukemia; a previous classification was error-prone, because 618 
the 'classical' cell-surface markers of healthy cells do not correctly identify the 619 
corresponding population in disease, whereas a richer signature allows accurate 620 
identification (Levine et al., 2015). Monitoring rare immune populations first discovered in 621 
a normal setting can help zero in on the relevant aberrations in disease. For example, the 622 
rare population associated with VDJ recombination first identified by trajectory analysis of 623 
B cell development (Bendall et al., 2014) is expanded in pediatric Acute Lymphoblastic 624 
Leukemia, and drastically more so in recurrence (Gary Nolan, unpublished results).  625 
The greatest impact, at least in the short term, is likely to be in cancer. Early 626 
studies used single-cell qPCR to investigate the origin of radioresistance in cancer stem 627 
cells (Diehn et al., 2009) and to dissect the heterogeneity and distortions of cellular 628 
hierarchy in colon cancer (Dalerba et al., 2011). With the advent of high-throughput 629 
methods, single-cell genome analysis has been used to study the clonal structure and 630 
evolution of tumors in both breast cancer (Wang et al., 2014) and acute lymphoblastic 631 
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leukemia (Gawad et al., 2014), and to infer the order of earliest mutations that cause acute 632 
myeloid leukemia (Corces-Zimmerman et al., 2014; Jan et al., 2012).  633 
In recent studies of melanoma (Tirosh et al., 2016a), glioblastoma (Patel et al., 634 
2014), low-grade glioma (Tirosh et al., 2016b), and myeloproliferative neoplasms (Kiselev 635 
et al., 2016), single-cell RNA-seq of fresh tumors resected directly from patients readily 636 
distinguished among malignant, immune, stromal and endothelial cells. Among the 637 
malignant cells, it identified distinct cell states – such as cancer stem cells (Patel et al., 638 
2014; Tirosh et al., 2016b), drug-resistant states (Tirosh et al., 2016a), proliferating and 639 
quiescent cells (Patel et al., 2014; Tirosh et al., 2016a; Tirosh et al., 2016b) – and related 640 
them to each other, showing, for example, that only stem-like cells proliferate in low-641 
grade glioma (Tirosh et al., 2016b) and that individual sub-clones can be readily identified 642 
in one patient (Kiselev et al., 2016). Among the non-malignant cells, it found distinct 643 
functional states for T-cells, and revealed that, while activation and exhaustion programs 644 
are coupled, the exhausted state is also controlled by an independent regulatory program 645 
in both human tumors (Tirosh et al., 2016a) and a mouse model (Singer et al., 2016). To 646 
associate patterns observed in a few (5-20) patients with effects on clinical phenotypes, 647 
single-cell based signatures were used to deconvolute hundreds of bulk tumor profiles 648 
that had been collected with rich clinical information (Levine et al., 2015; Patel et al., 2014; 649 
Tirosh et al., 2016a).  650 
 651 
<L1>Molecular mechanisms: intracellular and inter-cellular circuits</L1> 652 
A Human Cell Atlas can also shed light on the molecular mechanisms that control 653 
cell type, differentiation, responses and states – within cells, between cells, as well as 654 
between cells and their tissue matrix.  655 
For example, over the past several decades, biologists have sought to infer the 656 
circuitry underlying gene regulation by observing correlations between the expression of 657 
particular regulators and specific cellular phenotypes, drawing inferences about 658 
regulation, and testing their models through targeted genetic perturbations. Single-cell 659 
data provide a massive increase not only in the quantity of observations, but also in the 660 
range of perturbations. The number of cells profiled in a single-cell RNA-seq experiment 661 
can far exceed the number of profiles produced even by large consortia (such as ENCODE, 662 
FANTOM, TCGA, and GTEx). Moreover, each single cell is a perturbation system in which 663 
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the levels of regulatory molecules vary naturally – sometimes subtly, sometimes 664 
dramatically – due to both stochastic and controlled phenomena within a single genetic 665 
background, providing rich information from which to reconstruct cellular circuits 666 
(Krishnaswamy et al., 2014; Sachs et al., 2005; Shalek et al., 2013; Stewart-Ornstein et al., 667 
2012).  668 
Initial studies have shown that such analyses can uncover intracellular regulators 669 
governing cell differentiation and response to stimuli. For example, co-variation of RNA 670 
levels across a modest number of cells from a relatively 'pure' population of immune 671 
dendritic cells responding to a pathogen component was sufficient to connect antiviral 672 
transcription factors to their target genes, because of asynchrony in the responses (Shalek 673 
et al., 2013). Similarly, co-variation analysis of a few hundred Th17 cells spanning a 674 
continuum from less to more pathogenic states revealed regulators that control 675 
pathogenicity, but not other features, such as cell differentiation (Gaublomme et al., 2015). 676 
Co-variation identified a role for pregnenolone biosynthesis in the response of Th2 cells to 677 
helminth infection (Mahata et al., 2014), and new regulators of pluripotency in mouse 678 
embryonic stem cells (Kolodziejczyk et al., 2015). Computationally ordering cells along a 679 
time-course of development provides another way to infer regulators – a strategy that has 680 
been successful in, for example, differentiating B cells (Bendall et al., 2014), myoblasts 681 
(Trapnell et al., 2014), neurons (Habib et al., 2016a; Shin et al., 2015), and T helper cells 682 
(Lönnberg et al., 2017). Finally, when circuitry is already known, variation across single 683 
cells can be used to infer exquisite – and functionally important – quantitative distinctions 684 
about how signal is processed and propagated. An elegant example is a recent analysis of 685 
signaling pathways downstream from the T cell receptor, where single-cell proteomics 686 
data has shown how the same cellular circuitry processes signals differently in naïve and 687 
antigen-exposed T cells (Krishnaswamy et al., 2014). 688 
Beyond transcriptome analysis, single-cell multi-omic profiles (Box 1) will improve 689 
the inference of cellular circuitry by connecting regulatory mechanisms and their targets 690 
(Tanay and Regev, 2017). For example, simultaneous measurement of chromatin 691 
accessibility and RNA levels may help identify which regulatory regions – and by inference 692 
which trans–acting regulators – control the levels of which genes. Concomitant 693 
measurement of DNA mutations and transcriptional profiles in cancer cells may allow 694 
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similar causal connections to be drawn, as has been recently shown for mutations in the 695 
CIC gene and the expression of its regulatory targets (Tirosh et al., 2016b).  696 
Studies can be extended from naturally occurring variation among cells to 697 
engineered perturbations, by using pooled CRISPR libraries to manipulate genes and 698 
reading out both the perturbation and its effects on cellular phenotype in single cells – for 699 
example, by single-cell RNA-Seq (Adamson et al., 2016; Dixit et al., 2016; Jaitin et al., 2016). 700 
A cell atlas can also help shed light on intercellular communication, based on 701 
correlated profiles across cell types and patients. For example, analysis of single-cell 702 
profiles from many small clusters of a few aggregated cells allowed the construction of a 703 
cell-cell interaction network in the bone marrow, uncovering specific interaction between 704 
megakaryocytes and neutrophils, as well as between plasma cells and neutrophil 705 
precursors (Alexander van Oudenaarden, unpublished results). Cell-cell interactomes 706 
have also been inferred from profiles of purified cell populations, based on the secreted 707 
and cell surface molecules that they express (Ramilowski et al., 2015).  708 
In tumors from melanoma patients, gene-expression analysis (involving single-cell 709 
data obtained from some patients and bulk tumor data from many more patients, 710 
deconvoluted based on signatures learned from the single cells) found genes that are 711 
expressed in one cell type, but whose expression levels are correlated with the proportion 712 
of a different cell type that does not express them; this analysis revealed that high 713 
expression of the complement system in cancer-associated fibroblasts in the tumor 714 
microenvironment is correlated with increased infiltration of T cells (Tirosh et al., 2016a). 715 
Analysis of individual subcutaneous adipose stem cells revealed the existence of a novel 716 
cell population that negatively controls the differentiation of the resident stem cells into 717 
adipocytes, thus influencing adipose tissue growth and homeostasis (Bart Deplancke, 718 
unpublished results). In breast cancer tissues, spatial analysis of multiplex protein 719 
expression by imaging mass cytometry (Giesen et al., 2014) allowed classification of 720 
infiltrating immune cells and malignant cells based on the neighborhood of surrounding 721 
cells, highlighting new functional interactions (Bernd Bodenmiller, personal 722 
communication).  723 
 724 
<L1>A user's guide to the Human Cell Atlas: applications in research and 725 
medicine</L1> 726 
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The Human Genome Project had a major impact on biomedicine by providing a 727 
comprehensive reference, a DNA sequence in which answers could be readily looked up 728 
and from which unique 'signatures' could be derived (e.g., to recognize genes on 729 
microarrays or protein fragments in mass spectrometry). A Human Cell Atlas could 730 
provide similar benefits from basic research to clinically relevant applications.  731 
Scientists will be able, for example, to look up precisely in which cell types a gene 732 
of interest is expressed and at which level. Today, it is surprisingly challenging to obtain 733 
definitive answers for most human genes beyond tissue- or organ-level resolution, 734 
although there have been pioneering efforts for the brain and immune system in mouse 735 
(Bakken et al., 2016; Hawrylycz et al., 2012; Kim and Lanier, 2013; Miller et al., 2014) and for 736 
protein expression in human (Thul et al., 2017; Uhlen et al., 2015). Yet, the question is of 737 
enormous importance to basic biologists studying development or comparing a model 738 
system to human biology, medical scientists examining the effect of a disease-causing 739 
mutation, and drug developers concerned about the potential toxicities of a small 740 
molecule or a CAR-T cell targeting a specific protein (Brudno and Kochenderfer, 2016).  741 
Researchers will also be able to derive expression signatures that uniquely identify 742 
cell types. Such signatures provide a starting point for a vast range of experimental assays 743 
– from molecular markers for isolating, tagging, tracing or manipulating cells in animal 744 
models or human samples, to characterization of the effect of drugs on the physiological 745 
state of a tissue. Such descriptors of cellular identity will be widely used in clinical assays. 746 
For example, today's Complete Blood Count (CBC), a census of a limited number of blood 747 
components, may be supplemented by a 'CBC 2.0' that provides a high-resolution picture 748 
of the nucleated cells, including the number and activity states of each type in comparison 749 
with healthy reference samples. Analogous measures should be possible for other tissues 750 
as well. For example, gut biopsies from patients with ulcerative colitis or colon cancer 751 
could be analyzed for the type, response, state and location of each of the diverse 752 
epithelial, immune, stromal and neural cells that comprise them. 753 
 754 
<L1>Toward a Human Cell Atlas</L1> 755 
How might the biomedical community build a Human Cell Atlas? As with the 756 
Human Genome Project, a robust plan will best emerge from wide-ranging scientific 757 
discussions and careful planning involving biologists, technologists, pathologists, 758 
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physicians, surgeons, computational scientists, statisticians, and others. As noted above, 759 
various discussions have taken place for over two years about the idea of a comprehensive 760 
Human Cell Atlas, as well as about specific atlases for the brain and the immune system. 761 
Several pilot efforts are already underway. Moreover, over the past year discussions have 762 
been underway to create an initial plan for a Human Cell Atlas Project (which is 763 
articulated in the White Paper mentioned above). Among the key points for consideration 764 
are the following:  765 
<L2>Phasing of goals</L2> 766 
 While the overall goal is to build a comprehensive atlas with diverse molecular 767 
measurements, spatial organization, and interpretation of cell types, histology, 768 
development, physiology and molecular mechanisms, it will be wise to set intermediate 769 
goals for 'draft' atlases at increasing resolution, comprehensiveness, and depth of 770 
interpretation. The value of a phased approach was illustrated by the Human Genome 771 
Project, which defined milestones along the way (genetic maps, physical maps, rough-772 
draft sequence, finished sequence) that held the project accountable and provided 773 
immediate utility to the scientific community.  774 
<L2>Sampling strategies</L2> 775 
While an adult human has ~2 x 1013 nucleated cells, it is neither possible nor 776 
necessary to study them all to recover the fine distinctions among human cells. The key 777 
will be to combine sound statistical sampling, biological enrichment purification, and 778 
insights from studies of model organisms. It is likely beneficial to apply an adaptive, 779 
iterative approach with respect to both the number of cells and depth of profiles, as well 780 
as anatomical coverage and spatial resolution in the tissue, with initial sparse sampling 781 
driving decisions about further sampling. This adaptive approach, termed a 'Sky Dive', 782 
adjusts as resolution increases (and is further described in the HCA White Paper). 783 
Such approaches can be facilitated by experimental techniques that allow fast and 784 
inexpensive 'banking' of partially processed samples, to which one can return for deeper 785 
analysis as methods mature. Advances in handling fixed or frozen tissues would further 786 
facilitate the process (Box 1). With respect to depth of profiling, recent studies suggest the 787 
utility of a mixed strategy: relatively low coverage of the transcriptome can identify many 788 
cell types reliably (Heimberg et al., 2016; Shekhar et al., 2016) and a smaller set of deep 789 
profiles can be help interpret the low-coverage data to further increase detection power. 790 
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As a result, the 'Sky Dive' begins with large-scale uniform sampling, follows with stratified 791 
sampling, and then employs specialized sampling at lower throughput. 792 
<L2>Breadth of profiles</L2> 793 
The atlas must combine two branches – a cellular branch, focused on the 794 
properties of individual cells, and a spatial branch, describing the histological organization 795 
of cells in the tissue. For the cellular branch, massively parallel transcriptome analysis of 796 
individual single cells or nuclei will likely be the workhorse for efforts in the first few 797 
years. However, other robust, high-throughput profiling methods are rapidly emerging, 798 
including techniques for studying chromatin, genome folding, and somatic mutations at 799 
single-cell resolution (Box 1). For the spatial branch, in situ analysis of the spatial patterns 800 
of RNA, proteins, and potentially epigenomics will be equally important. While some of 801 
these methods are already rapidly maturing, others will benefit from focused development 802 
efforts, as well as from cross-comparison among different techniques. Fortunately, most 803 
can be applied to preserved tissue specimens, allowing specimens collected now to be 804 
analyzed later, as methods mature.  805 
<L2>Biological scope</L2> 806 
It will be important to consider the balance among tissue samples from healthy 807 
individuals at various stages; small cohorts of individuals with diseases; and samples from 808 
model organisms, where key developmental stages are more accessible and manipulations 809 
more feasible. Well-chosen pilot projects could help refine strategies and galvanize 810 
communities of biological experts. Some communities and projects would be organized 811 
around organs (e.g., liver, heart, brain), others around systems (e.g., the immune system) 812 
or disease (e.g., cancer), the latter distributed across many organs and tissues.  813 
As outlined in the HCA White Paper, the first draft of the atlas might pursue 814 
roughly a dozen organs and systems, each from up to 100 individuals, collected across 3–4 815 
geographical sites; each would be analyzed to obtain both cellular and spatial data, by 816 
means of uniform to stratified sampling. Tissue from post-mortem examination will play a 817 
key role, because it is the only way to obtain samples from a single individual across the 818 
entire body. These efforts will be complemented, where possible, by biopsy or resection 819 
material from healthy research participants, and by whole organs obtained from deceased 820 
transplant donors after transplantation organs have been harvested. In some cases, such as 821 
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the immune system, samples from individuals with a disease will be included to probe 822 
different functional states of a system.  823 
The full atlas, will ultimately describe at least 10 billion cells, covering all tissues, 824 
organs, and systems. Specimens will come from both healthy research participants and 825 
small cohorts of patients with relevant diseases. The cells and tissues will be studied 826 
using a broad range of techniques, to obtain cellular and spatial information, from 827 
samples designed to  represent the world's diversity. As with previous genomic projects, 828 
the Human Cell Atlas will be bounded in its resolution (with respect to the rarity of cell 829 
types/states and the spatial resolution), its coverage of disease and diversity (broadly 830 
representative but not obviating the need for direct genetic and clinical studies), and its 831 
functional assessment (to validate the existence of identified cells and facilitate – but not 832 
perform – detailed functional characterization).  833 
<L2>Model organisms</L2> 834 
The Human Genome Project and the broader scientific community benefitted 835 
from insights learned from genome projects conducted in parallel in model organisms. 836 
These projects empowered functional studies in model organisms, ushered a new era of 837 
comparative genomics, and provided important technical lessons. By analogy, we 838 
envision that key 'sister' atlases in model organisms will be developed in parallel and in 839 
coordination with the Human Cell Atlas. These projects should not delay progress on the 840 
human atlas (or vice versa), because current techniques are already directly applicable to 841 
biomedical research on human samples.  842 
In some cases, model organism atlases can use techniques that are not possible in 843 
humans, such as engineering animals to facilitate lineage tracing. In many cases, the 844 
extensive validation and functional follow-up studies that can be performed in model 845 
organisms will help validate 'by proxy' conclusions drawn in the human atlas. Finally, 846 
comparing the atlases across organisms will provide invaluable lessons in evolution and 847 
function. 848 
<L2>Quality</L2> 849 
In creating a reference map to be used by thousands of investigators, it is critical to 850 
ensure that the results are of high quality and technically reproducible. This is especially 851 
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important in view of the inherent biological variation and expected measurement noise. 852 
Substantial investment will be needed in the development, comparison, and 853 
dissemination of rigorous protocols, standards, and benchmarks. Both individual groups 854 
and larger centers will likely have important roles in defining and ensuring high quality. It 855 
will also be important that the collected samples be accompanied by excellent clinical 856 
annotations, captured in consistent meta-data across the atlas. 857 
Tissue processing poses special challenges, including the need for robust methods 858 
for dissociating samples into single cells so as to preserve all cell types, fixation for in situ 859 
methods, and freezing for transport. A related challenge is the difference in the 860 
amenability of specific cell types for different assays (T cells are very small and yield lower 861 
quality scRNA-seq; the fat content in adipocyte is challenging for many spatial methods; 862 
many neurons cannot currently be isolated with their axons and dendrites from adult 863 
tissue). Careful attention will also be needed to data generation and computational 864 
analysis, including validated standard operating procedures for experimental methods, 865 
best practices, computational pipelines, and benchmarking samples and data sets to 866 
ensure comparability.   867 
<L2>Global equity</L2> 868 
Geographical atlases of the Earth were largely developed to serve global power 869 
centers. The Human Cell Atlas should be designed to serve all people: it should span 870 
genders, ethnicities, environments, and the global burden of diseases – all of which are 871 
likely to affect the molecular profiles of cells and must be characterized to maximize the 872 
atlas's benefits. The project itself should encourage and support the participation of 873 
scientists, research centers and countries from around the globe, while recognizing the 874 
value of respecting and learning from diverse populations, cultures, mores, beliefs, and 875 
traditions.  876 
<L2>Open data</L2> 877 
The Human Genome Project made clear the power of open data that can be used 878 
by all and freely combined with other datasets. A Human Cell Atlas should similarly be an 879 
open endeavor, to the full extent permitted by participants' wishes and legal regulation. 880 
While the underlying sequence data contains many polymorphisms that make it 881 
'identifiable', it should be possible to map the data onto 'standard models' of each gene to 882 
substantially mitigate this issue. To make the atlas useful, it will be critical to develop data 883 
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platforms that can provide efficient aggregation and storage, quality control, analytical 884 
software, and user-friendly portals. 885 
<L2>Flexibility</L2> 886 
A Human Cell Atlas Project should be intellectually and technologically flexible. 887 
The project should embrace the fact that its biological goals, experimental methods, 888 
computational approaches, overall scale, and criteria for 'completion' will evolve rapidly as 889 
insights and tools develop. For historical context, it is useful to remember that discussions 890 
about a Human Genome Project began before the development of automated DNA 891 
sequencing machines, the polymerase chain reaction, or large-insert DNA cloning, and the 892 
project drove technological progress on many fronts. Moreover, the criteria for a 'finished' 893 
genome sequence were only agreed upon during the last third of the project. 894 
<L2>Impact on the scientific community</L2> 895 
Large-scale efforts, such as a Human Cell Atlas, must be careful to appropriately 896 
weigh the benefits to science and individual scientists with the potential costs. We 897 
consider the key benefits to the broad scientific community to include: the core scientific 898 
knowledge and discoveries that will result from having a reference map; the 899 
empowerment of scientists working across any tissue or cell type to pursue their research 900 
more precisely and effectively; the development, hardening and dissemination of 901 
experimental techniques and computational methods in the context of big-data settings, 902 
all of which will be openly shared; the inclusive and maximally open Human Cell Atlas 903 
community, inviting participation by all individual labs and research centers; and the 904 
coordination of efforts that would otherwise be unconnected, less extensive, and more 905 
expensive. 906 
At the same time, we must be aware of potential pitfalls, including: premature 907 
restriction to specific technologies or approaches, which might limit innovation in a fast-908 
moving field; implicit restriction of participation, based on available resources; and 909 
diversion of funding from other research directions. The unique organization and 910 
community of the Human Cell Atlas Project will tackle these potential challenges by 911 
committing to open membership, to the open and immediate data release with no 912 
restrictions, and to open-source code for all computational approaches. We hope that the 913 
new information and technology generated will more than repay the costs of the project 914 
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by increasing the speed and efficiency of biomedical research throughout the scientific 915 
community. 916 
<L2>Engagement with the non-scientific community</L2> 917 
The general public is a key stakeholder community for the Human Cell Atlas. 918 
Proper public engagement should involve many communities, including interested 919 
members of the public, citizen-scientists, schoolchildren, teachers and, where appropriate, 920 
research participants. Engagement will take diverse forms, including traditional media, 921 
social media, video and, importantly, direct sharing of the project's data. Across all 922 
channels, it will be important to articulate the goals, principles and motivations of the 923 
project. While explaining the intended benefits to the public with respect to advancing 924 
disease biology, drug discovery and diagnostics, it will be equally important to avoid 925 
'hype': that is, we need to avoid making promises and raising expectations that are 926 
unrealistic in content or timing.  927 
<L2>Forward looking</L2> 928 
Any data produced today will be easier, faster, more accurate and cheaper to 929 
produce tomorrow. Any intermediate milestones achieved during the project will be 930 
supplanted by deeper, broader, more accurate, and more comprehensive successors within 931 
a few short years.  However, as we define the goal of a Human Cell Atlas Project, we 932 
should view it not as a final product, but as a critical stepping-stone to a future when the 933 
study of human biology and medicine is increasing tractable.  934 
 935 
<L2>Conclusion</L2> 936 
 The past quarter-century has shown again and again the value of the scientific 937 
community joining together in collaborative efforts to generate and make freely available 938 
systematic information resources to accelerate scientific and medical progress in tens of 939 
thousands of laboratories around the world. The Human Cell Atlas builds on this rich 940 
tradition, extending it to the fundamental unit of biological organization: the cell. 941 
Many challenges will arise along the way, but we are confident that they can be 942 
met through scientific creativity and collaboration. It is time to begin. 943 
944 
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Box 1: Key experimental methods for single-cell genomics 945 
 946 
Over the past several years, powerful approaches have emerged that make it possible to 947 
measure molecular profiles and signatures at single-cell resolution. The field remains very 948 
active, with new methods being rapidly developed and existing ones improved. 949 
Single-cell RNA-Seq (scRNA-seq) refers to a class of methods for profiling the 950 
transcriptome of individual cells. Some may take a census of mRNA species by focusing on 951 
3'- or 5'-ends (Islam et al., 2014; Macosko et al., 2015), while others assess mRNA structure 952 
and splicing by collecting near-full-length sequence (Hashimshony et al., 2012; Ramskold 953 
et al., 2012). Strategies for single-cell isolation span manual cell picking, initially used in 954 
microarray studies (Eberwine et al., 1992; Van Gelder et al., 1990), FACS-based sorting into 955 
multi-well plates (Ramskold et al., 2012; Shalek et al., 2013), microfluidic devices (Shalek et 956 
al., 2014; Treutlein et al., 2014), and, most recently, droplet-based (Klein et al., 2015; 957 
Macosko et al., 2015) and microwell-based (Fan et al., 2015; Yuan and Sims, 2016) 958 
approaches. The droplet and microwell approaches, which are currently coupled to 3'-end 959 
counting, have the largest throughput, allowing rapid processing of tens of thousands of 960 
cells simultaneously in a single sample. scRNA-seq is typically applied to freshly 961 
dissociated tissue, but emerging protocols use fixed cells (Nichterwitz et al., 2016; 962 
Thomsen et al., 2016) or nuclei isolated from frozen or lightly fixed tissue (Habib et al., 963 
2016b; Lake et al., 2016). Applications to fixed or frozen samples would simplify the 964 
process flow for scRNA-seq, as well as open the possibility of using archival material. 965 
Power analyses provides a framework for comparing the sensitivity and accuracy of these 966 
approaches (Svensson et al., 2016; Ziegenhain et al., 2016). Finally, there has been progress 967 
in scRNA-Seq with RNA isolated from live cells in their natural microenvironment using 968 
transcriptome in vivo analysis (Lovatt et al., 2014).  969 
Mass cytometry (CyTOF) and related methods allow multiplexed measurement of 970 
proteins based on antibodies barcoded with heavy metals (Bendall et al., 2014; Levine et 971 
al., 2015). In contrast to comprehensive profiles, these methods involve pre-defined 972 
signatures and require an appropriate antibody for each target, but they can process many 973 
millions of cells for a very low cost per cell. They are applied to fixed cells. Recently, the 974 
approach has been extended to the measurement of RNA signatures through multiplex 975 
hybridization of nucleic-acid probes tagged with heavy metals (Frei et al., 2016). 976 
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Single-cell genome and epigenome sequencing characterizes the cellular genome. 977 
Genomic methods aim either to characterize the whole genome or capture specific pre-978 
defined regions (Gao et al., 2016). Epigenomic methods may capture regions based on 979 
distinctive histone modifications (single-cell ChIP-Seq; Rotem et al., 2015a), accessibility 980 
(single-cell ATAC-Seq; Buenrostro et al., 2015; Cusanovich et al., 2015), or likewise 981 
characterize DNA methylation patterns (single-cell DNAme-Seq; Farlik et al., 2015; Guo et 982 
al., 2013; Mooijman et al., 2016; Smallwood et al., 2014) or 3D organization (single-cell Hi-983 
C; Nagano et al., 2013; Ramani et al., 2016). Combinatorial barcoding strategies have been 984 
used to capture measures of accessibility and 3D organization in tens of thousands of 985 
single cells (Cusanovich et al., 2015; Ramani et al., 2016). Single cell epigenomics methods 986 
are usually applied to nuclei, and can thus use frozen or certain fixed samples. Some 987 
methods, such as single-cell DNA sequencing, are currently applied to relatively few cells, 988 
due to the size of the genome and the sequencing depth required. Other methods, such as 989 
single-cell analysis of chromatin organization (by either single-cell ATAC-Seq; Buenrostro 990 
et al., 2015; Cusanovich et al., 2015) or single-cell ChIP-Seq (Rotem et al., 2015a), currently 991 
yield rather sparse data, which presents analytic challenges and benefits from large 992 
numbers of profiled cells. Computational analyses have begun to address these issues by 993 
pooling of signal across cells and across genomic regions or loci (Buenrostro et al., 2015; 994 
Rotem et al., 2015a) and by imputation (Angermueller et al., 2016). 995 
Single-cell multi-omics techniques aim to collect two or more types of data 996 
(transcriptomic, genomic, epigenomic, and proteomic) from the same single cell. Recent 997 
studies have simultaneously profiled the transcriptome together with either the genome 998 
(Angermueller et al., 2016; Dey et al., 2015; Macaulay et al., 2015), the epigenome 999 
(Angermueller et al., 2016), or protein signatures (Albayrak et al., 2016; Darmanis et al., 1000 
2016; Frei et al., 2016; Genshaft et al., 2016). Efforts to combine three and more approaches 1001 
are underway (Cheow et al., 2016). Multi-omic methods could help fill in causal chains 1002 
from genetic variation to regulatory mechanisms and phenotypic outcome in health and 1003 
in disease, especially cancer.  1004 
Multiplex in situ analysis and other spatial techniques aim to detect a limited number 1005 
of nucleic acids and/or proteins in situ in tissue samples – by hybridization (for RNA), 1006 
antibody staining (for proteins), sequencing (for nucleic acids), or other tagging strategies. 1007 
These in situ results can then be used to map massive amounts of single-cell genomic 1008 
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information from dissociated cells onto the tissue samples providing important clues 1009 
about spatial relationships and cell-cell communication. Some strategies for RNA 1010 
detection, such as MERFISH (Chen et al., 2015b; Moffitt et al., 2016b) or Seq-FISH (Shah et 1011 
al., 2016), combine multiplex hybridization with microscopy-based quantification to assess 1012 
distributions at both the cellular and subcellular level; other early studies have performed 1013 
in situ transcription (Tecott et al., 1988), followed by direct manual harvesting of cDNA 1014 
from individual cells (Crino et al., 1996; Tecott et al., 1988). Some approaches for protein 1015 
detection, such as Imaging Mass Cytometry (Giesen et al., 2014) and Mass Ion Bean 1016 
Imaging (Angelo et al., 2014), involve staining a tissue specimen with antibodies, each 1017 
labeled with a barcode of heavy metals, and rastering across the sample to measure the 1018 
proteins in each 'pixel'. This technique permits the reconstruction of remarkably rich 1019 
images. Finally, more recent studies have performed RNA-seq in situ in cells and in 1020 
preserved tissue sections (Ke et al., 2013; Lee et al., 2014). Many in situ methods can benefit 1021 
from tissue clearing and/or expansion to improve detection and spatial resolution (Chen 1022 
et al., 2015a; Chen et al., 2016a; Moffitt et al., 2016a; Yang et al., 2014). The complexity and 1023 
accuracy of these methods continues to improve with advances in sample handling, 1024 
chemistry and imaging. Various methods are also used, for example, to measure 1025 
transcriptomes in situ with barcoded arrays (Stahl et al., 2016). 1026 
Cell lineage determination. Because mammals are not transparent and have many 1027 
billions of cells, it is not currently possible to directly observe the fate of cells by 1028 
microscopy. Various alternative approaches have been developed (Kretzschmar and Watt, 1029 
2012). In mice, cells can be genetically marked with different colors (Barker et al., 2007) or 1030 
DNA barcodes (Lu et al., 2011; Naik et al., 2013; Perie and Duffy, 2016), and their offspring 1031 
traced during development. Recent work has used iterative CRISPR-based genome editing 1032 
to generate random genetic scars in the fetal genome and use them to reconstruct lineages 1033 
in the adult animal (McKenna et al., 2016). In humans, where such methods cannot be 1034 
applied, human cell lineages can be monitored experimentally in vitro, or by 1035 
transplantation of human cells to immunosuppressed mice (Morton and Houghton, 2007; 1036 
O'Brien et al., 2007; Richmond and Su, 2008), or can be inferred from in vivo samples by 1037 
measuring the DNA differences between individual sampled cells, arising from random 1038 
mutations during cell division, and using the genetic distances to construct cellular 1039 
phylogenies, or lineages (Behjati et al., 2014; Shapiro et al., 2013).  1040 
 
 
 
 
34 
 1041 
Box 2: On Exactitude in Science. Jorge Luis Borges (1946)  1042 
“. . . In that Empire, the Art of Cartography attained such Perfection that the map of a 1043 
single Province occupied the entirety of a City, and the map of the Empire, the entirety of 1044 
a Province. In time, those Unconscionable Maps no longer satisfied, and the 1045 
Cartographers Guilds struck a Map of the Empire whose size was that of the Empire, and 1046 
which coincided point for point with it. The following Generations, who were not so fond 1047 
of the Study of Cartography as their Forebears had been, saw that that vast map was 1048 
Useless, and not without some Pitilessness was it, that they delivered it up to the 1049 
Inclemencies of Sun and Winters. In the Deserts of the West, still today, there are 1050 
Tattered Ruins of that Map, inhabited by Animals and Beggars; in all the Land there is no 1051 
other Relic of the Disciplines of Geography.”  1052 
Purportedly from Suárez Miranda, Travels of Prudent Men, Book Four, Ch. XLV, Lérida, 1053 
1658. 1054 
 1055 
1056 
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Figure legends 1057 
 1058 
Figure 1: A hierarchical view of human anatomy. A graphical depiction of the 1059 
anatomical hierarchy from organs (such as the gut), to tissues (such as the epithelium in 1060 
the crypt in the small intestine), to their constituent cells (such as epithelial, immune, 1061 
stromal and neural cells).  1062 
 1063 
Figure 2: Anatomy: cell types and tissue structure. The first three plots show single 1064 
cells (dots) embedded in low-dimensional space based on similarities between their RNA-1065 
expression profiles (A, C) or protein-expression profiles (B), using either t-stochastic 1066 
neighborhood embedding (A,B) or circular projection (C) for dimensionality reduction 1067 
and embedding. (A) Bi-polar neurons from the mouse retina; reprinted from Shekhar et 1068 
al., 2016 with permission from Elsevier. (B) Human bone marrow immune cells;  reprinted 1069 
from Levine et al., 2015 with permission from Elsevier. (C) Immune cells from the mouse 1070 
spleen; reprinted from Jaitin et al., 2014 with permission from AAAS. (D) Histology. 1071 
Projection of single-cell data onto tissue structures: image shows the mapping of 1072 
individual cells onto locations in the marine annelid brain, based on the correspondence 1073 
(color bar) between their single-cell expression profiles and independent FISH assays for a 1074 
set of landmark transcripts; adapted from Achim et al., 2015 with permission from 1075 
Macmillan Publishers Limited. 1076 
 1077 
Figure 3: Developmental trajectories. Each plot shows single cells (dots; colored by 1078 
trajectory assignment, sampled time point, or developmental stage) embedded in low-1079 
dimensional space based on their RNA (A-C) or protein (D) profiles, using different 1080 
methods for dimensionality reduction and embedding: Gaussian process patent variable 1081 
model  (A); t-stochastic neighborhood embedding (B, D); diffusion maps (C). 1082 
Computational methods then identify trajectories of pseudo-temporal progression in each 1083 
case. (A) Myoblast differentiation in vitro; reprinted from Lönnberg et al., 2017 with 1084 
permission from AAAS. (B) Neurogenesis in the mouse brain dentate gyrus; reprinted 1085 
from Habib et al., 2016a with permission from AAAS.  (C) Embryonic stem cell 1086 
differentiation in vitro; adapted from Haghverdi et al., 2016 with permission from 1087 
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Macmillan Publishers Limited.  (D) Early hematopoiesis; adapted from Setty et al., 2016 1088 
with permission from Macmillan Publishers Limited. 1089 
 1090 
Figure 4. Physiology. Each plot shows single cells (dots) embedded in low-dimensional 1091 
space on the basis of their RNA profile, based on predefined gene signatures (A) or PCA 1092 
(B, C), highlighting distinct dynamic processes. (A) The cell cycle in mouse hematopoietic 1093 
stem and progenitor cells; adapted under terms of CC BY 4.0 from Scialdone et al., 2015. 1094 
(B) Response to lipopolysaccharide (LPS) in mouse immune dendritic cells; adapted from 1095 
Shalek et al., 2014 with permission from Macmillan Publishers Limited. (C) Variation in 1096 
the extent of pathogenicity in mouse Th17 cells; reprinted from Gaublomme et al., 2015 1097 
with permission from Elsevier. 1098 
 1099 
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